Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,591,881
+$5,563,133 QoQ
Shares Held
68,491
+5.1% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#159
of 846 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Vanguard Investments Australia, Ltd. holds $326,895,412 across 28 Diagnostics & Research names. NTRA ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
189,557 | $95,036,297 | |
| 2 | DHR |
Danaher Corp /De/
|
324,429 | $61,797,235 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
40,523 | $21,332,928 | |
| 4 | A |
Agilent Technologies, Inc.
|
145,107 | $19,274,562 | |
| 5 | WAT |
Waters Corp /De/
|
50,404 | $18,903,516 | |
| 6 | NTRA |
Natera, Inc.
This page
|
68,491 | $18,591,881 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
86,557 | $16,724,543 | |
| 8 | ILMN |
Illumina, Inc.
|
76,038 | $13,369,761 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,591,881 | 68,491 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $13,028,748 | 65,147 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||